Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jacob L. van Dam"'
Autor:
Daphne H.M. Droogh, Jacob L. van Dam, Jesse V. Groen, Mark G.J. de Boer, Joffrey van Prehn, Casper H.J. van Eijck, Bert A. Bonsing, Alexander L. Vahrmeijer, Bas Groot Koerkamp, J. Sven D. Mieog
Publikováno v:
HPB. John Wiley & Sons Inc.
Background: Abdominal infections account for substantial morbidity after pancreatoduodenectomy. Contaminated bile is the presumed main risk factor, and prolonged antibiotic prophylaxis might prevent these complications. This study compared organ/spac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69e3299698773dce4a0c0206014ae04a
https://pure.eur.nl/en/publications/9f24261f-b859-4ccf-9462-5a2f003bbdb9
https://pure.eur.nl/en/publications/9f24261f-b859-4ccf-9462-5a2f003bbdb9
Autor:
Marjolein Y.V. Homs, Roeland F. de Wilde, Casper H.J. van Eijck, Quisette P. Janssen, Geertjan van Tienhoven, Marc G. Besselink, Johanna W. Wilmink, Jacob L van Dam, Bas Groot Koerkamp, Hjalmar C. van Santvoort
Publikováno v:
European Journal of Cancer, 160, 140-149. Elsevier Ltd.
European Journal of Cancer, 160, 140-149. Elsevier Limited
European Journal of Cancer, 160, 140-149. Pergamon
Dutch Pancreatic Cancer Group 2022, ' Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer : A meta-analysis of randomised controlled trials ', European Journal of Cancer, vol. 160, pp. 140-149 . https://doi.org/10.1016/j.ejca.2021.10.023
European Journal of Cancer, 160, 140-149. Elsevier Limited
European Journal of Cancer, 160, 140-149. Pergamon
Dutch Pancreatic Cancer Group 2022, ' Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer : A meta-analysis of randomised controlled trials ', European Journal of Cancer, vol. 160, pp. 140-149 . https://doi.org/10.1016/j.ejca.2021.10.023
INTRODUCTION: Neoadjuvant therapy may improve survival compared with upfront surgery in patients with resectable and borderline resectable pancreatic cancer, but high-quality evidence is lacking.METHODS: We systematically searched for randomised tria
Autor:
Vincent E de Meijer, Marielle M.E. Coolsen, Michael F. Gerhards, Casper H.J. van Eijck, J. Sven D. Mieog, Hjalmar C. van Santvoort, Bobby K Pranger, Jacob L van Dam, Bert A. Bonsing, Geert Kazemier, Jesse V. Groen, Olivier R. Busch, Koert P. de Jong, Ruben H J de Kleine, Joost M. Klaase, Erwin van der Harst, Bas Groot Koerkamp, I. Quintus Molenaar, Marc G. Besselink, Martijn W J Stommel
Publikováno v:
HPB, 23(8), 1175-1184. ELSEVIER SCI LTD
Hpb, 23, 8, pp. 1175-1184
Hpb, 23(8), 1175-1184. ELSEVIER SCI LTD
HPB: The official journal of the International Hepato Pancreato Biliary Association, 23(8), 1175-1184. John Wiley and Sons Inc.
HPB, 23(8), 1175-1184. John Wiley & Sons Inc.
Hpb, 23, 1175-1184
Hpb, 23, 8, pp. 1175-1184
Hpb, 23(8), 1175-1184. ELSEVIER SCI LTD
HPB: The official journal of the International Hepato Pancreato Biliary Association, 23(8), 1175-1184. John Wiley and Sons Inc.
HPB, 23(8), 1175-1184. John Wiley & Sons Inc.
Hpb, 23, 1175-1184
BACKGROUND: The aim of this study was to determine pancreatic surgery specific short- and long-term complications of pediatric, adolescent and young adult (PAYA) patients who underwent pancreatic resection, as compared to a comparator cohort of adult
Autor:
Hjalmar J. van Santvoort, Joost J. Nuyttens, Quisette P. Janssen, Hongchao Qi, Johanna W. Wilmink, Roeland F. de Wilde, Casper H.J. van Eijck, Geertjan van Tienhoven, Alice C. Wei, Bas Groot Koerkamp, Marc G. Besselink, Marjolein Y.V. Homs, Isabelle G. Kivits, Jacob L van Dam
Publikováno v:
Annals of Surgical Oncology
Annals of surgical oncology, 28(13), 8297-8308. Springer New York
Annals of Surgical Oncology, 28(13), 8297-8308. Springer New York
Janssen, Q P, van Dam, J L, Kivits, I G, Besselink, M G, van Eijck, C H J, Homs, M Y V, Nuyttens, J J M E, Qi, H, van Santvoort, H J, Wei, A C, de Wilde, R F, Wilmink, J W, van Tienhoven, G & Groot Koerkamp, B 2021, ' Added Value of Radiotherapy Following Neoadjuvant FOLFIRINOX for Resectable and Borderline Resectable Pancreatic Cancer : A Systematic Review and Meta-Analysis ', Annals of Surgical Oncology, vol. 28, no. 13, pp. 8297-8308 . https://doi.org/10.1245/s10434-021-10276-8
Annals of surgical oncology, 28(13), 8297-8308. Springer New York
Annals of Surgical Oncology, 28(13), 8297-8308. Springer New York
Janssen, Q P, van Dam, J L, Kivits, I G, Besselink, M G, van Eijck, C H J, Homs, M Y V, Nuyttens, J J M E, Qi, H, van Santvoort, H J, Wei, A C, de Wilde, R F, Wilmink, J W, van Tienhoven, G & Groot Koerkamp, B 2021, ' Added Value of Radiotherapy Following Neoadjuvant FOLFIRINOX for Resectable and Borderline Resectable Pancreatic Cancer : A Systematic Review and Meta-Analysis ', Annals of Surgical Oncology, vol. 28, no. 13, pp. 8297-8308 . https://doi.org/10.1245/s10434-021-10276-8
Background The added value of radiotherapy following neoadjuvant FOLFIRINOX chemotherapy in patients with resectable or borderline resectable pancreatic cancer ((B)RPC) is unclear. The objective of this meta-analysis was to compare outcomes of patien
Autor:
Robert C. Minnee, Joke I. Roodnat, Hendrikus J. A. N. Kimenai, Jan N. M. IJzermans, Elsaline Rijkse, Jacob L van Dam
Publikováno v:
Transplant International, 33(5), 483-496. Wiley-Blackwell Publishing Ltd
The prognosis of kidney transplant recipients (KTR) with vascular calcification (VC) in the aorto-iliac arteries is unclear. We performed a systematic review and meta-analysis to investigate their survival outcomes. Studies from January 1st, 2000 unt
Autor:
Fleur van der Sijde, Jacob L. van Dam, Bas Groot Koerkamp, Brigitte C. M. Haberkorn, Marjolein Y. V. Homs, Daniëlle Mathijssen, Marc G. Besselink, Johanna W. Wilmink, Casper H. J. van Eijck
Publikováno v:
Journal of oncology, 2022:8549487. Hindawi Publishing Corporation
Journal of Oncology, 2022:8549487. Hindawi Publishing Corporation
van der Sijde, F, van Dam, J L, Groot Koerkamp, B, Haberkorn, B C M, Homs, M Y V, Mathijssen, D, Besselink, M G, Wilmink, J W & van Eijck, C H J 2022, ' Treatment Response and Conditional Survival in Advanced Pancreatic Cancer Patients Treated with FOLFIRINOX : A Multicenter Cohort Study ', Journal of oncology, vol. 2022, 8549487 . https://doi.org/10.1155/2022/8549487
Journal of Oncology, 2022:8549487. Hindawi Publishing Corporation
van der Sijde, F, van Dam, J L, Groot Koerkamp, B, Haberkorn, B C M, Homs, M Y V, Mathijssen, D, Besselink, M G, Wilmink, J W & van Eijck, C H J 2022, ' Treatment Response and Conditional Survival in Advanced Pancreatic Cancer Patients Treated with FOLFIRINOX : A Multicenter Cohort Study ', Journal of oncology, vol. 2022, 8549487 . https://doi.org/10.1155/2022/8549487
Background. FOLFIRINOX chemotherapy is the current Dutch standard of care for locally advanced (LAPC) and metastatic pancreatic cancer (PDAC) patients with good performance status. The objective of this study was to evaluate real-world response rates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b73cca9fbbb969f5c2839c81fe7c7325
https://research.vumc.nl/en/publications/500d80e6-50ad-4482-ae9e-b15e0ced6b82
https://research.vumc.nl/en/publications/500d80e6-50ad-4482-ae9e-b15e0ced6b82
Autor:
Alice C. Wei, Marc G. Besselink, Joost J. Nuyttens, Casper H.J. van Eijck, Roeland F. de Wilde, Jacob L van Dam, Marjolein Y.V. Homs, Geertjan van Tienhoven, Johanna W. Wilmink, Hongchao Qi, Bas Groot Koerkamp, Hjalmar J. van Santvoort, Quisette P. Janssen, Isabelle G. Kivits
Publikováno v:
Annals of surgical oncology, 28, 485-487. Springer New York
Annals of Surgical Oncology, 28(SUPPL 3), 485-487. Springer New York
Annals of Surgical Oncology, 28(SUPPL 3), 485-487. Springer New York
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b51bb733f96396c6e1d72d8956ea7a0
https://pure.amc.nl/en/publications/aso-visual-abstract(38423ea5-4185-492c-bde7-c727d0c211b6).html
https://pure.amc.nl/en/publications/aso-visual-abstract(38423ea5-4185-492c-bde7-c727d0c211b6).html
Autor:
Bert A. Bonsing, Stijn van Roessel, Marc G. Besselink, Jesse V. Groen, Casper H.J. van Eijck, Joanne Verheij, Alexander L. Vahrmeijer, J. Sven D. Mieog, Michael Doukas, Hein Putter, Labrinus van Manen, Arantza Farina Sarasqueta, Bas Groot Koerkamp, Jacob L van Dam
Publikováno v:
Pancreas, 50(8), 1218-1229. Lippincott Williams and Wilkins
Pancreas, 50(8), 1218-1229. LIPPINCOTT WILLIAMS & WILKINS
Pancreas, 50(8), 1218-1229. LIPPINCOTT WILLIAMS & WILKINS
OBJECTIVES: The portal vein (PV)-superior mesenteric vein (SMV) margin is the most affected margin in pancreatic cancer. This study investigates the association between venous resection, tumor invasion in the resected PV-SMV, recurrence patterns, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcd22b24298800abc02b06218f6ac49e
https://hdl.handle.net/1887/3277587
https://hdl.handle.net/1887/3277587
Autor:
Jacob L van Dam, Johanna W. Wilmink, Bas Groot Koerkamp, Quisette P. Janssen, Marc G. Besselink, Marjolein Y.V. Homs, Geertjan van Tienhoven
Publikováno v:
Journal of Clinical Oncology, 39(15). American Society of Clinical Oncology
TPS4171 Background: Neoadjuvant therapy has several potential advantages over upfront surgery in patients with localized pancreatic cancer; more patients receive systemic treatment, fewer patients undergo futile surgery, and R0 resection rates are hi
Autor:
Quisette P. Janssen, Jacob L. van Dam, Laura R. Prakash, Deesje Doppenberg, Christopher H. Crane, Casper H.J. van Eijck, Susannah G. Ellsworth, William R. Jarnagin, Eileen M. O’Reilly, Alessandro Paniccia, Marsha Reyngold, Marc G. Besselink, Matthew H.G. Katz, Ching-Wei D. Tzeng, Amer H. Zureikat, Bas Groot Koerkamp, Alice C. Wei
Publikováno v:
Journal of the National Comprehensive Cancer Network, 20(7), 783-791. Cold Spring Publishing LLC
Journal of the National Comprehensive Cancer Network : JNCCN, 20(7), 783-791. Cold Spring Publishing LLC
J Natl Compr Canc Netw
Journal of the National Comprehensive Cancer Network : JNCCN, 20(7), 783-791. Cold Spring Publishing LLC
J Natl Compr Canc Netw
Background: The value of neoadjuvant radiotherapy (RT) after 5-fluorouracil with leucovorin, oxaliplatin, and irinotecan, with or without dose modifications [(m)FOLFIRINOX], for patients with borderline resectable (BR) pancreatic ductal adenocarcinom